Oliver Weigert
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Molecular Biology
- Genetics top 2%
- Immunology
- Co-authors
- Wolfgang HiddemannDavid M. WeinstockMartin DreylingMichael UnterhaltVindi JurinovićKim A. SharpJustin R. CrossCraig B. Thompson
- Topics
- Lymphoma Diagnosis and Treatment (50 papers)Chronic Lymphocytic Leukemia Research (20 papers)Viral-associated cancers and disorders (18 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Oliver Weigert
70 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 68
- Pathology and Forensic Medicine 788
- Oncology 657
- Molecular Biology 403
- Genetics 403
- Immunology 178
Countries citing papers authored by Oliver Weigert
This map shows the geographic impact of Oliver Weigert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Weigert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Weigert more than expected).
Fields of papers citing papers by Oliver Weigert
This network shows the impact of papers produced by Oliver Weigert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Weigert. The network helps show where Oliver Weigert may publish in the future.
Co-authorship network of co-authors of Oliver Weigert
This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Weigert. A scholar is included among the top collaborators of Oliver Weigert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Weigert. Oliver Weigert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 41 | |
| 5 | 13 | |
| 6 | 15 | |
| 7 | 61 | |
| 8 | 1 | |
| 9 | 40 | |
| 10 | 45 | |
| 11 | 4 | |
| 12 | 64 | |
| 13 | 150 | |
| 14 | Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle | 2 |
| 15 | 40 | |
| 16 | 17 | |
| 17 | 1 | |
| 18 | 47 | |
| 19 | 19 | |
| 20 | 7 |
About Oliver Weigert
Oliver Weigert is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 74 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (50 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Viral-associated cancers and disorders (18 papers). The work is most often cited by research in Pathology and Forensic Medicine (788 citations), Genetics (403 citations) and Oncology (657 citations). Oliver Weigert has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Wolfgang Hiddemann, David M. Weinstock, Martin Dreyling, Michael Unterhalt, Vindi Jurinović, Kim A. Sharp, Justin R. Cross, Craig B. Thompson, Patrick S. Ward and Chao Lü. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.